EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Substance Use and Sex Index version 2 (SUSI‐2): Validation of a brief questionnaire for the measurement of behaviours associated with transmission of blood borne viruses and sexually transmitted infections

Brendan Clifford iD, Raimondo Bruno, Liam Acheson iD, Michael E Cecilio, Krista J Siefried iD, Jack Freestone, Vincent J Cornelisse iD, Brendan Crozier, Nicky Bath, Nadine Ezard

Addiction · 2026

DOI: 10.1111/add.70253 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Addiction, 2026. Verfasst von Brendan Clifford und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Clinical Research on Emerging Drugs, University of New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: Sexually Transmitted Diseases, Sexual Behavior, Substance-Related Disorders, Blood-Borne Infections. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: St Vincent's Health Australia Inclusive Health Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study sought to validate a community‐acceptable Substance Use & Sex Index (SUSI) for use in substance use intervention research. SUSI aims to measure behaviours associated with the transmission of blood‐borne viruses (BBV) and sexually transmitted infections (STI) among people who use substances and incorporate contemporary sexual and drug practices.

Design

Validation of a self‐administered online behavioural questionnaire. Setting and Participants An Australian anonymous online questionnaire advertised through health services and social media resulted in 289 respondents with a mean age 35 years (standard deviation [SD] 10.9 years).

Measurements

A 26‐item scale assessing BBV‐ and STI‐associated behaviours based on previous piloting and expert review was assessed for scale structure using exploratory and confirmatory factor analytic approaches. Item Response Theory (IRT) analyses were applied in decisions to retain and categorise items. Item weightings were defined following expert consensus informed by local BBV, STI and HIV epidemiological profiles. Test–retest reliability was examined on a subsample (n = 98) over three to five days. Criterion validity of the new SUSI‐2 scale was examined in comparison to the HIV Risk‐taking Behaviour subscale of the Opiate Treatment Index (OTI‐HRBS).

Findings

Factor analysis identified a two‐factor model (“sex”; “drugs with sex”), with moderate magnitude correlation (r = 0.38; 95% confidence interval [CI] 0.19–0.54) between factors and acceptable model fit (p = 0.061). IRT discrimination was statistically significant for all items (p < 0.05). Kappa values for test–retest reliability (n = 98 subsample) ranged from 0.66 to 1.00 with high agreement (all above 87%). Free text responses indicated the questionnaire items were acceptable to respondents, with minimal suggestion for improvements. There was a statistically significant positive correlation between the SUSI‐2 and OTI‐HRBS sex subscales (weighted r = 0.63, p < 0.001) and between the SUSI‐2 sex with drugs and OTI‐HRBS drug subscale (weighted r = 0.21, p < 0.01). Four additional items were retained to reflect local other BBV and STI transmission risk.

Conclusions

The Substance Use & Sex Index 2 (SUSI‐2) appears to be a valid and acceptable two‐factor brief scale for the measurement of behaviours associated with blood‐borne viruses and sexually transmitted infections for use in substance use interventional research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sexually Transmitted DiseasesSexual BehaviorSubstance-Related DisordersBlood-Borne InfectionsHumansMaleAdultFemaleSurveys and QuestionnairesReproducibility of ResultsAustraliaMiddle AgedYoung AdultFactor Analysis, StatisticalRisk-TakingAdolescent

Stichwörter der Autor:innen

behaviour change measurementblood borne virusclinical trialshuman immunodeficiency virus (HIV)injecting drug usesexually transmitted infections

Autor:innen und Institutionen

  • National Centre for Clinical Research on Emerging Drugs, University of New South Wales, Sydney, Australia.
  • Alcohol and Drug Service, St Vincent's Hospital Sydney, Sydney, Australia.
  • National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
  • Drug and Alcohol Clinical Research and Improvement Network, NSW Health, Sydney, Australia.
  • School of Psychological Sciences, University of Tasmania, Hobart, Australia.
  • The Kirby Institute, University of New South Wales, Sydney, Australia.

ORCID-Profile: Brendan Clifford, Liam Acheson, Krista J Siefried, Vincent J Cornelisse

Förderung

  • St Vincent's Health Australia Inclusive Health Program

Zitieren

APA

Clifford, B., Bruno, R., Acheson, L., Cecilio, M. E., Siefried, K. J., Freestone, J., Cornelisse, V. J., Crozier, B., Bath, N., & Ezard, N. (2026). Substance Use and Sex Index version 2 (SUSI‐2): Validation of a brief questionnaire for the measurement of behaviours associated with transmission of blood borne viruses and sexually transmitted infections. Addiction. https://doi.org/10.1111/add.70253

Vancouver

Clifford B, Bruno R, Acheson L, Cecilio ME, Siefried KJ, Freestone J, et al. Substance Use and Sex Index version 2 (SUSI‐2): Validation of a brief questionnaire for the measurement of behaviours associated with transmission of blood borne viruses and sexually transmitted infections. Addiction. 2026. doi:10.1111/add.70253

BibTeX
@article{Clifford2026,
  author = {Clifford, Brendan and Bruno, Raimondo and Acheson, Liam and Cecilio, Michael E and Siefried, Krista J and Freestone, Jack and Cornelisse, Vincent J and Crozier, Brendan and Bath, Nicky and Ezard, Nadine},
  title = {Substance Use and Sex Index version 2 (SUSI‐2): Validation of a brief questionnaire for the measurement of behaviours associated with transmission of blood borne viruses and sexually transmitted infections},
  journal = {Addiction},
  year = {2026},
  doi = {10.1111/add.70253}
}
Kostenlos starten →